BOK Financial’s Collegium Pharmaceutical COLL Stock Holding History

BOK Financial’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$517K	Buy	14,295 +3,818	+36%	+$130K	0.01%	550
2026 Q1	$346K	Sell	10,477 -5,255	-33%	-$222K	0.01%	608
2025 Q4	$728K	Sell	15,732 -84	-0.5%	-$3.51K	0.01%	475
2025 Q3	$553K	Buy	15,816 +72	+0.5%	+$2.5K	0.01%	550
2025 Q2	$466K	Buy	15,744 +111	+0.7%	+$3.17K	0.01%	589
2025 Q1	$467K	Sell	15,633 -1,290	-8%	-$39.4K	0.01%	573
2024 Q4	$557K	Buy	16,923 +3,403	+25%	+$113K	0.01%	533
2024 Q3	$539K	Sell	13,520 -1,688	-11%	-$60.2K	0.01%	555
2024 Q2	$490K	Buy	+15,208	New	+$527K	0.01%	612
2018 Q3	–	Sell	-16,170	Closed	-$386K	–	929
2018 Q2	$386K	Buy	16,170 +8,250	+104%	+$203K	0.01%	737
2018 Q1	$202K	Buy	+7,920	New	+$189K	0.01%	857

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

BOK Financial's COLL Position: Q2 2026 in Review

BOK Financial increased its Collegium Pharmaceutical (COLL) stake by 36% in Q2 2026, buying an estimated $130K and bringing the position to 14,295 shares worth $517K. The position accounts for 0.01% of the portfolio, ranked #550.

BOK Financial first reported a position in COLL in Q1 2018 and has held it in 11 quarters since. The position peaked at $728K in Q4 2025. 280 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

BOK Financial held 14,295 shares of Collegium Pharmaceutical worth $517K as of Q2 2026.
BOK Financial bought 3,818 Collegium Pharmaceutical shares in Q2 2026, an estimated $130K.
Collegium Pharmaceutical made up 0.01% of BOK Financial's portfolio in Q2 2026, its #550 holding.
BOK Financial first reported a position in Collegium Pharmaceutical in Q1 2018 and has held it in 11 quarters since.
BOK Financial's Collegium Pharmaceutical position peaked at $728K in Q4 2025.
280 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on BOK Financial's 13F filing for Q2 2026, filed 10 Aug 2026.